Skip to main content

CERENOME, INC.

For the period ended Mar 31, 2025. Filed May 30, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 30, 2025

CNSY$0.68+19.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity/(Deficit

(In thousands, except share data)

Convertible · Additional · Total
preferred stock · Common stock · Treasury Stock · paid-in · Accumulated · stockholders’
Shares · Amount · Shares · Amount · Shares · Amount · capital · deficit · (deficit)/equity
Balance at December 31, 20231,952$—4,522,656$5(78,559)$(126)$479,274$(480,501)$(1,348)
Stock-based compensation——————146—146
Purchase of treasury stock————(179,866)(374)——(374)
Net loss———————(3,261)(3,261)
Balance at March 31, 20241,952$—4,522,656$5(258,425)$(500)$479,420$(483,762)$(4,837)
Balance at December 31, 20241,952$—6,154,758$6(258,425)$(500)$485,024$(493,479)$(8,949)
Stock-based compensation——————148—148
Exercise of pre-funded warrants——6,535,7317——(7)—(0)
Exercise of Series B Warrants from May 2024 PIPE——497,824———882—882
Exchange of warrants for notes payable——————(3,694)—(3,694)
Issuance of common stock, prefunded warrants and warrants for debt repayment——4,069,7384——5,369—5,373
Net loss———————(17,401)(17,401)
Balance at March 31, 20251,952$—17,258,051$17(258,425)$(500)$487,722$(510,880)$(23,641)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.